MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3233/rnn-190909

Медицинская библиотека · Restorative neurology and neuroscience · 2019

Acute and chronic effects of single dose memantine after controlled cortical impact injury in adult rats.

Abrahamson Eric E, Poloyac Samuel M, Dixon C Edward, Dekosky Steven T, Ikonomovic Milos D

СтатьяПоддержка исследования: вне правительства СШАПоддержка правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Altered glutamatergic neurotransmission after traumatic brain injury (TBI) contributes to excitotoxic cell damage and death. Prevention or suppression of such changes is a desirable goal for treatment of TBI. Memantine (3,5-dimethyl-1-adamantanamine), an uncompetitive NMDA receptor antagonist with voltage-dependent open channel blocking kinetics, was reported to be neuroprotective in preclinical models of excitotoxicity, brain ischemia, and in TBI when administered prophylactically, immediately, or within minutes after injury.

METHODS

The current study examined effects of memantine administered by single intraperitoneal injection to adult male rats at a more clinically relevant delay of one hour after moderate-severe controlled cortical impact (CCI) injury or sham surgery. Histopathology was assessed on days 1, 7, 21, and 90, vestibulomotor function (beam balance and beam walk) was assessed on days 1-5 and 71-75, and spatial memory (Morris water maze test, MWM) was assessed on days 14-21 and 83-90 after CCI injury or sham surgery.

RESULTS

When administered at 10 mg/kg, but not 2.5 or 5 mg/kg, memantine preserved cortical tissue and reduced neuronal degeneration 1 day after injury, and attenuated loss of synaptophysin immunoreactivity in the hippocampus 7 days after injury. No effects of 10 mg/kg memantine were observed on histopathology at 21 and 90 days after CCI injury or sham surgery, or on vestibulomotor function and spatial memory acquisition assessed during any of the testing periods. However, 10 mg/kg memantine resulted in trends for improved search strategy in the MWM memory retention probe trial.

CONCLUSIONS

Administration of memantine at a clinically-relevant delay after moderate-severe CCI injury has beneficial effects on acute outcomes, while more significant improvement on subacute and chronic outcomes may require repeated drug administration or its combination with another therapy.

Для цитирования: Abrahamson Eric E, Poloyac Samuel M, Dixon C Edward, Dekosky Steven T, Ikonomovic Milos D. Acute and chronic effects of single dose memantine after controlled cortical impact injury in adult rats.. Restorative neurology and neuroscience. 2019. DOI: 10.3233/rnn-190909.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.